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Human Papillomavirus (HPV) is a global health issue that is transmitted sexually and 
affects both genders. Evidence shows that approximately 79 million people are affected 
in the United States with 14 million newly affected yearly. The Centers for Disease 
Control and Prevention indicates that teens and young adults under age 25 are at 
particular risk, so it is important to begin the vaccination series between 9 and 17 years of 
age.  Parental voluntary acceptance of HPV vaccine for their minor children was noted as 
a problem in a clinic in Northwest Indiana, and 8% clinic HPV series completion rate is 
significantly lower than the targeted federal goal of 80% by 2020. A literature review 
indicated that an educational intervention provided by healthcare professionals could 
serve as one of the strongest predictors of HPV vaccine acceptance. The purpose of this 
project was to develop an evidence-based parental educational process to support 
providers’ influence on parents of children ages 9 to 17 to provide consent for the HPV 
vaccine. The project goals focused on parental knowledge, beliefs, and attitudes. The 
clinic providers will utilize assessment tools validated by experts and evidence-based 
educational materials to promote HPV and HPV vaccine awareness. The theoretical 
foundations of the project were the theory of reasoned action and Pathman’s pipeline that 
target the parents directly through individual educational sessions to achieve knowledge 
gain and behavioral change. Implementation of educational materials by clinic providers 
may improve parental knowledge of HPV and the HPV vaccine acceptance. Social 
change may result from the integration of the project into clinical practice to increase the 
HPV vaccine acceptance rates, which will ultimately reduce the effects of HPV and its 
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The proposed developmental project dedicated to parents who worried about their 
children’s safety regarding the Human Papillomavirus vaccine. The willingness and 
cooperation to share their beliefs, cynicism, led to the development of this educational 
intervention, provided by the providers to enhance parents’ knowledge of the HPV and 
the HPV vaccine was well appreciated. The parents’ acceptance of the proposed 
educational intervention will lead to increase in the HPV vaccine administration at the 
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Section 1: Nature of the Project 
Introduction 
Human Papillomavirus (HPV) infection is the most common sexually transmitted 
infection in men and women in the United States. Approximately 79 million people are 
currently infected with HPV, with about 14 million people newly infected yearly in the 
United States (Centers for Disease Control [CDC], 2014). United States population-based 
studies conducted by the CDC demonstrated that 66% of cervical cancer, 55% of vaginal 
cancers, 79% of anal cancers, and 62% of oropharyngeal cancer attributed to HPV Types 
16 or 18. Yearly, an estimated 26,000 new cancers attributed to HPV in which about 
17,000 are diagnosed in women and 9,000 are diagnosed in men (CDC, 2014).  
The CDC (2010) is committed to the vision of health for all by the year 2020. The 
CDC identified immunization and infectious disease control as their number 23 targeted 
objectives in ensuring population health by the year 2020 (healthypeople.gov, 2010). The 
information obtained from Children Hoosier Immunization Registry Program (CHIRP) 
showed that in the state of Indiana in 2014, only 7% completed HPV three-dose series in 
the state of Indiana, with only 8% completed the three-dose series in Children and Family 
Health Clinic (CFHC), and about 5% completion in the Lake County Indiana, where the 
above named clinic located (K. Cameron, personal communication, February, 5th, 2015).  
CHIRP is where individual clinics must document their vaccine record in the state of 
Indiana for uniformity and easy access by all providers due to different usage of 
electronic health record (EHR). 
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There was the need to advocate for HPV vaccination administration. A lack of 
HPV vaccine acceptance or uptake will most likely increase HPV infection prevalence. 
During most interactions in office visits with patient ages 9 to 17 years old, I observed 
that parents does not consent easily for HPV vaccination and some parents lacked 
knowledge of HPV infections and the available vaccines thereby affecting HPV vaccine 
acceptance and administration. The review of literature indicated the most common 
barriers to parental acceptance of HPV vaccine are cultural and religious beliefs, parental 
attitude, public health resources, and intervention.  
Parental decisions not to consent to the HPV vaccine was due to a lack of 
knowledge, behavior, attitude, and their belief that their child or children are not sexually 
active and do not require HPV vaccination (Thomas, Strickland, DiClemente, Higgins, & 
Habber, 2012; Walhart, 2012). Other parents believed that their teen was too young to be 
sexually active or too young to have contacted a sexually transmitted infection (STI). 
Parents may have a low perceived risk of infection, concerns about vaccine safety, and 
concern about promoting sexual promiscuity by vaccinating their adolescent with HPV 
vaccine (Okoronkwo, Sieswerda, Cooper, Binette, & Todd, 2012).  
Some providers do not promote HPV vaccination due to the burden of explaining 
the HPV vaccine relationship to HPV infection during an encounter with cynical parents 
who have negative perceptions of the vaccine (McCave, 2010). The provider may feel 
uncomfortable discussing sexual activity and HPV vaccine, particularly with parent of the 
preadolescents during a wellness clinic visit (McCave, 2010). Krawczyk et al. reported 
that educational interventions enhance parental HPV knowledge and vaccination 
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intentions thereby increasing HPV vaccination rates. Developing an evidence-based 
educational intervention for parents and patients will be a goal in achieving increasing 
rates of human papillomavirus vaccine uptake.  
Problem Statement 
The problem addressed in this study was the development of an educational 
intervention needed to increase the HPV vaccination rate among children age 9 to 17 
years. Educational intervention provided by health care providers and professionals 
serves as one of the strongest predictors of HPV vaccine acceptance (Dunne et al., 2007; 
Krawczyk et al., 2012). According to the CDC Morbidity and Mortality weekly report in 
January 2014, there was a decline in acceptance of HPV vaccine from 2011 to 2012. This  
decline puts vaccine rates far below the Healthy People 2020 targets. The CDC also 
indicated that the coverage for adolescent girls with the first three-doses in 2012 shows 
wide variation from state to state, especially with the three-dose coverage of HPV 
vaccine for adolescent girls. In Mississippi, the coverage is as low as 12.1%, and in 
Rhode Island the coverage is as high as 57.7%. The coverage data revealed a concerning 
trend among adolescent girls that needs immediate public health interventions.  
The above information serves as a call to action regarding the nonvoluntary 
acceptance of the parents at the CFHC during child wellness clinic visits in terms of HPV 
vaccine consent and was deemed a concern triggering the conduct of a needs assessment. 
The needs assessment was necessary to ensure that the intervention will meet the targeted 
population objective and goals of designing the program. The goal of conducting a needs 
assessment must be to identify health care needs (meaning gaps) of the identified 
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population, educational need as in this identified population health issue, and the resource 
needs of the targeted population to increase HPV vaccine uptake (Hodges & Videto, 
2011). The federal goal is to vaccinate 80% of boys and girls against HPV by 2020 
(McCabe, 2014). The rate of HPV vaccination completion for the three-dose series in 
children ages 9 to 17 are low in the state of Indiana in general as indicated in Table 1. At 
the CFHC, the coverage was very low compared to other vaccines as evidenced by 
nonvoluntary acceptance of the parent during child wellness visit. For Lake County 
Indiana, in which the CFHC clinic is located, the coverage was no different. Table 1 
illustrates these facts. For the table below, the date of birth range was from January 1, 
1997 to December 31, 2005. All information was obtained from CHIRP. 
Table 1 
HPV 3 Dose Series Completion Rates: 9-17 Years of Age 
As of January 1, 2014 to 
December 31, 2014 
   As of July 1, 2014 to 
December 31, 2014 
  

































































K. Cameron, personal communication, February, 5th, 2015   
The table showed there was a need for the student in charge of the program in 
collaboration with the CFHC providers’ to develop an educational intervention to educate 
5 
 
the parents of the target population in order to increase their willingness to consent to 
HPV vaccine administration during a wellness clinic visit. The gap in knowledge needs to 
be fixed through an educational intervention to prevent the HPV infection and its 
sequelae among this age group, while at the same time increasing HPV vaccine 
acceptance, thereby promoting wellness. The proposed strategies for increasing 
adolescent HPV vaccine coverage rates in the United States, according to the CDC 
(2014) report are as follows: 
• Ensure education of patients, parents and providers about the vaccine and 
the disease that it prevents. 
• Provide a reduction in out of pocket cost for HPV vaccine for the patient 
with insurance since their other counterpart, who are Medicaid eligible 
obtains the vaccine at no cost under the Vaccines for Children program 
(VFC). 
• Utilize alternative sites other than clinic settings to reach the target 
population such as schools.  
• Targeting government programs that would add HPV vaccine as part of 
the school requirement considering HPV sequelae as in (genital warts, 
oropharyngeal, and cervical cancer), since school requirement has increase 
other vaccine coverage in the past as in (Tetanus, diphtheria, pertussis, 
Measles, Meningitis etc.). 
To ensure that the project question, which was focused on an educational 
intervention to impact the decision of parents to have their children ages 9 to 17 years old 
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vaccinated against HPV, was properly addressed, a PICOT strategy was developed.  The 
PICOT helps narrow the search for literature and to lay out the questions that inform the 
current practices while at the same time improving patient outcomes (Elkins, 2010). The 
proposed project problem to be addressed was outline in this PICOT question  
P: The population of interest was parents of children age 9 to 17 years old.  
I: The proposed intervention was parental education on HPV infection and 
available vaccines.  
C: The comparison group or current standard was pre and post education 
influence on HPV vaccination to see if the HPV three-dose series completion 
increases from 8% in 2014 post education program development and integration. 
O: The proposed desired outcome was that education would increase parental 
knowledge about HPV infections and thereby increase a vaccination acceptance.  
T: The proposed time intervals for the above project problem will be about three 
to four month period. 
 
Purpose Statement 
The purpose of the proposed quality improvement (QI) project was to develop an 
educational intervention to increase the uptake of the HPV vaccine at the CFHC located 
in Lake County Indiana. The collaborative team for the proposed project will provide a 
ready-made comprehensive HPV written pamphlet and educational plan in the form of a 
parental guide to HPV vaccination that will be available during the clinic visit (Appendix 
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The proposed recommendation also includes a one to one parental counseling or 
education session related to HPV and HPV vaccine during wellness child visit.  
Goals and Objectives 
The proposed educational intervention targeted the parents of children ages 9 to 
17 years old in the CFHC in northwest Indiana. The goals and objectives of the 
educational intervention were to increase the acceptance of HPV vaccine in the clinic 
population based on an educational intervention strategy to impact parents’ decision to 
have their children ages 9 to 17 given the HPV vaccine. According to CHIRP report of 
children in CFHC with birth date ranges from 01/01/1997 to 12/31/2005, out of 213-220 
children, only 17-18 completed the HPV three dose series. This quality improvement 
project was developed to target the children at CFHC from the first dose to the three-
doses completion during the wellness visit and via a subsequent telephone call to ensure 
adequate coverage, while at the same time attempting to reach the federal target goal of 
vaccinating 80% boys and girls in 2020 (McCabe, 2014). 
Theoretical Foundation 
Theory informs nursing practice. Theories clarify and define nursing practice 
through provision of goals for assessment and intervention while at the same time 
providing direction leading to the improvement in the client outcomes of care (McEwen 
& Wills, 2011). The theory appropriate to the population health issue was the theory of 
reasoned action (TRA), also known as the theory of planned behavior (TPB). The TRA 
was widely used both nationally and internationally and accepted by most groups as a 
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source of establishing changes in the parental beliefs, attitude, behavior, and the 
intentions leading to their behavioral performances (White & Dudley-Brown, 2012).  
  To appropriately complement the identified proposed developmental project, 
Pathman’s pipeline model was used as an evidence-based model to reduce the gap in 
HPV vaccination issues. The model was developed by Pathman, a pediatrician, in 
collaboration with Konrad, Freed, Freeman, and Koch in 1996 to ensure patient 
compliance with the health provider recommendation for the vaccine (White & Dudley-
Brown, 2012). The theory and model supported the need for an educational intervention 
for the parents’ of children ages 9 to 17. TRA or TPB and Pathman’s pipeline model 
explained in detail in Section 2. 
Significance of the Project 
The Institute of Medicine (2010) recommended nurses to be full partners with 
other health care professionals in redesigning health care in the United States. In doing 
so, nurses are encouraged to be the lead for change in health care related issues and 
policy decisions to bridge the gap and advance health systems thereby improving patient 
outcomes of care. The development of an educational intervention for the parents’ of the 
identified population should lead to increased knowledge of HPV and HPV vaccine and 
thereby increased HPV vaccine acceptance. Parental knowledge increase will lead to a 
reduction in HPV infection and its sequelae. Increased parental knowledge will also 
promote health and well being among the targeted population in the long term. 
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Implication for Social Change 
A DNP graduate is expected to apply the scholarship of application in a clinical 
setting. DNPs graduates are expected to appraise everyday practice and provide the 
intervention that improved the practice. According to the DNP Essential III, the scholar 
applies knowledge to solve the practice problems through scholarship of application via 
translation of evidence-based knowledge, integration and dissemination of new 
knowledge to the advance clinical practice (American Association of Critical-Care 
Nurses [AACN], 2006). The Americans Nurse Association (ANA) code of ethics for 
nursing Number 2 indicates that the nurses primary responsibility is to show the 
commitment to the patient, whether as an individual, family, group, or community in the 
promotion of health and wellness (Zaccagnini & White, 2011).  
The development and integration of the proposed educational intervention project 
into the clinical practice will have a significant impact in the parents of the children aged 
9 to 17 years old by improving or changing their beliefs and barriers against HPV and 
HPV vaccine. The successful development and integration of the project into the clinical 
practice will improve the acceptance of HPV vaccine thereby reducing the effects of 
HPV infection in those identified population age group. Since HPV affects people 
anywhere irrespective of their geographical location, the program, if successfully 
integrated into the clinical practice, may have the potential impact in other clinics locally 
within the state, nationally as well as globally 
10 
 
Definitions of Terms 
Behavior: A specific behavior that should occur for the individual understanding 
of the needed action, for whom the action is to be performed, when and where applicable. 
According to the theory of reasoned action, individuals are rational and their behavior is 
link to their beliefs, attitudes, and their intentions. Based on the above, the individual 
must have a positive attitude towards the needed change, must be empowered and have 
control over the change and have the ability to perceive the change would promote 
positive influence within their social groups (White & Dudley-Brown, 2012).  
 Education: Parental education needed structure in such a way that would promote 
acceptance of the HPV vaccine and increase HPV vaccine rate. Sometimes, educational 
intervention culturally tailored to specific group of parents can promote understanding 
thereby promote health education and awareness. Novelas for television, radio, and print 
developed targeting Spanish-speaking communities with low level of literacy serves as a 
useful tools in increasing awareness of and interest in HPV vaccination among Hispanic 
parents (Kepka, Coronado, Rodriguez, & Thompson, 2011). 
Human Papillomavirus: HPV are groups of over 150 related viruses. They are 
referred to as papillomaviruses since sometimes-certain types may progress to cause 
warts, or papillomas and mostly are benign (noncancerous) in nature. Other types of HPV 
are associated with specific types of cancer and they referred to as high-risk, oncogenic 
or carcinogenic HPVs. Out of over 150 types of HPV, over 40 types can passed directly 
from person-to person contact. The infection from the HPV viruses may go unnoticed and 
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other times may progress to specific types of cancer as in cervical, genital or oral cancers 
(cancer.gov. 2014). 
Prevalence: The number of existing cases of a disease or health condition in a 
population at a designated time (Friis & Sellers, 2014, p.751). 
Incidence/Incidence rate: This is considered a measure of the risk of a specified 
health-related event within a given period in a specified population. It is measure in terms 
of incident rate, looking at the number of the new cases, the population at risk and the 
period in which the cases or incident accrue (Friis & Sellers, 2015). 
Immunization/Vaccination: The process by which all or part of a dead or 
weakened bacteria or virus in form of vaccine are been injected into the individuals to 
invoke an immunologic response (antibodies) that will fight against any microbes or 
infective organism. The effect mimics the natural infection with little or no risk to the 
recipient (Friis & Sellers, 2014).  The need for preventative health care in the form of 
primary care is one of the main agenda of the Affordable Health Care Act (ACA).  
Evidence strongly shows that preventative services such as immunization can 
substantially improve health outcomes.  The Advisory Committee on Immunization 
Practices (ACIP) of the CDC, identified 13 vaccines preventable diseases, for which the 
health benefits outweighs any associated risks for children or adults, or both (Bernstein, 
Chollet, & Peterson, 2010).     
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Assumptions and Limitations 
Assumptions  
Assumptions are beliefs about phenomena that one must accept to be the true. An 
assumption sometimes is based on accepted knowledge, beliefs, or values. An assumption 
may not be susceptible to testing; but philosophically argued (McEwen & Wills, 2011). 
1. An educational intervention should promote parental knowledge of HPV 
and HPV vaccine. 
2. An educational intervention should increase the decision of the parent to 
have their children ages nine to seventeen years old vaccinated against 
human papilloma virus. 
3. An educational intervention should increase HPV vaccine rate in the 
project clinic. 
4. An educational intervention should be cost effective without putting an 
additional cost to the sponsoring clinic. 
Limitations 
Limitations are the lack of theoretical and methodological ability of a particular 
study that may decrease the generalizability of the particular study findings (Grove, 
Burns & Gray, 2012). The following are the limitations for the present study. 
1. The educational intervention developed for the proposed QI project may 
not be generalizable in another clinic setting. 
2. The development, implementation and evaluation for this proposed QI 
project may not be applicable in another clinic setting. 
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3. I am employed at the study clinic (CFHC) at the time of the proposed QI 
project. As a result, my NP leadership may influence the educational 
intervention of the project. 
4. The lack of effective team participation from other clinic staff members 
and the providers including the clinic owner due to the clinic structure 
may limit the generalization of the project. 
5. The effect of time constraint by the other clinic providers to provide 
necessary educational materials and guidance to the study group parents 
may affect the result of the study. 
6. The lack of enough literature targeting males may have an effect in the 
generalization of the proposed QI project. 
Summary 
The Section 1 included a brief overview of HPV and parental influence on the 
acceptance of HPV vaccine. I provided a framework and research evidence that would 
guide the successful implementation of the developmental project. The successful 
implementation and the integration of the educational intervention project into the 
clinical practice could lead to the improvement in the acceptance of HPV vaccine, 
thereby reducing the effects of HPV infection in the identified population age group. 
Section 2 was a review of the literature and the theoretical framework with the 
conceptual model that support an educational intervention leading to increase parents’ 
decision to have their children ages 9 to 17 given the HPV vaccine. The first part of the 
Section 2 was a review of the specific and general literature informing HPV and HPV 
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vaccine. The section concluded with a theoretical framework from the context of the 
theory of reasoned action or theory of planned behavior and supported with Pathman’s 




Section 2: Review of Literature and Theoretical and Conceptual Framework 
Introduction 
The purpose of this quality improvement project was to develop and prepare a 
plan for implementation of an educational intervention that would have impact on the 
parents’ decision to have their children ages 9 to 17 given the HPV vaccine. The review 
of the literature justifies the need for an educational intervention leading to increase the 
parents’ decision to have their children given HPV vaccine. This section of the 
manuscript includes information on the synthesis of the scholarly literature related to 
HPV and the HPV vaccine. The section contains the information on the conceptual 
models and theoretical frameworks that guided the program development. 
Literature Search Strategy 
The search for evidence-based literature was conducted electronically using the 
following search engines or databases: CINAHL, Cochrane, Medline, ProQuest utilizing 
Walden University Library, as well as the CDC database from January to December, 
2014. Articles published more than 10 years ago were discarded to ensure that current 
information was used to inform the project. The search results produced evidence that 
was reviewed and rated. When possible, more than one research article was used to  
supported each of the terms and recommendations. The specific terms used for the search 






HPV is one of the sexually transmitted infections affecting both males and 
females. HPV is the most common sexually transmitted infection worldwide (Drewry, 
Garces-Palacio, & Scarinci, 2010; Palli, Mehta, & Aparasu, 2012; Walhart, 2012). 
Drewry et al. indicated that the HPV infection rate for sexually active women ranges 
from 20 to 80%. Prevalence figures showed about 6 million new infections yearly with at 
least 90% of cervical cancer diagnoses being associated with HPV infection. Palli et al. 
indicated that persistent exposure to the high-risk type of HPV increases the individual 
chances of developing cervical cancer. Palli et al. showed that HPV infection has been 
associated to other types of anogenital cancer, cervical cancer, and genital warts. The 
prevalence showed that about 20 million people in the United States are currently 
infected with HPV, with about 6.2 million within the age of 14 to 44 years affected 
annually.  
Walhart (2012) noted that about 75% of people will be affected, diagnosed, or 
experience one of the many HPV strains during their sexual lifetime. Walhart indicated 
that although adolescents represent only 25% of sexually active population, they have a 
50% higher prevalence of HPV exposure, which could be attributed to the combination of 
many factors as in sexual behavior, biological and cultural influences.  
In the United States, HPV is the most commonly transmitted sexual infection 
(Cates, Ortiz, Shafer, Romocki, & Coyne-Beasley, 2012; CDC, 2014; Dunne et al., 2007; 
Gamble, Klosky, Parra, & Randolph, 2010; Oldach & Katz, 2012; Sussman et al., 2007; 
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Thomas, 2008; Yitalo, Lee, & Mehta, 2013). HPV prevalence in United States showed an 
estimated overall infection of about 20 million to 79 million. An estimated 6.2 to 14 
million people aged 14 to 59 are newly or currently infected (CDC, 2014; Markowitz et 
al., 2014; Palli et al., 2012). A study of 32 counties of Ohio Appalachia departments of 
health also supported the HPV as a commonly transmitted infection in the United States 
(Oldach & Katz, 2012). An estimated prevalence rates of 42.5% for females aged 14-59 
years. 53.1 % for males aged 18-70 years who reported having sex only with females. 
About 53.8% among those aged 20-24 years (Markowitz et al., 2014; Oldach & Katz, 
2012).  
A woman in the State of Indiana loses her life every 3 days to cervical cancer on 
average. Cervical Cancer-Free Indiana (CCFIN) is a form of coalition that believes in 
providing educational information on the preventative services with available community 
resources help to prevent women from developing cervical cancer. CCFIN hopes to lower 
the rates of cervical cancer diagnosis by promoting awareness of HPV and its linkage to 
cervical cancer while at the same time increasing access to HPV vaccine (CCFIN, 2014). 
CCFIN in 2011 launched Cancer Education Network (CEW) program with the aim of 
providing face-to-face cervical cancer and HPV education prevention to the medically 
deprived patients in Marion County, Indiana clinic sites. Cervical cancer is 100% 
preventable; the purpose of this study was to provide the educational intervention that 
impact the parents’ decision in acceptance to give HPV vaccine to the targeted population 
age group study.  
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HPV is more prevalent among other ethnic groups (African-American and 
Hispanic) as well is the higher incidence of cervical cancer (CDC, 2014; Thomas, 2008; 
Yitalo et al., 2013). Based on the aforementioned, the Advisory Committee on 
Immunization Practices (ACIP) recommends routine vaccination with HPV4 or HPV2 for 
females and males aged 11-12 years. The committee also recommends vaccination for 
females age 13 to 26 years and males 13 to 21 years of age who are not yet immunized 
against HPV (Markowitz et al., 2014). 
Vaccine 
Approval of HPV vaccine for use in both females and males ages 9 to 26 and 9 to 
21 in 2006 and 2009 respectively was one of the public health breakthroughs in the 
history of health prevention. The first HPV vaccine (Gardasil) approved in June 2006 for 
people ages 9 to 26 years proved to be effective against HPV infection and its sequelae -  
cervical cancer/genital warts (Sussman et al., 2007).  Despite all of the above evidence, 
parents are resistant to consent for HPV vaccine administration for their child or children. 
Parental concerns to freely consent to HPV vaccine was due to lack of knowledge, as 
well as their belief that their child/children are not sexually active and do not require 
vaccination.  
Presently, HPV infection prevalence increases yearly, mostly in the United States. 
The increase is due to sexual activity preferences and parents’ being not well informed 
about the HPV vaccine availability and its effectiveness against cervical, oral, and anal 
cancer, as well as genital warts. In the U. S., Gardasil, produced by MERCK and 
approved by the Food and Drug Administration (FDA) in 2006, offered protection 
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against four different species of HPV that are six, 11, 16 and 18. The FDA just approved 
Gardasil nine packs that will provide more HPV and cancer protection. Gardasil nine 
packs covers the first four HPV strain covered presently as well as HPV Types 31, 33, 
45, 52, and 58. Gardasil used by females aged 9 to 26 years and males aged 9 to 15 years. 
Maximum protection provided HPV vaccine given prior the individual becoming infected 
with the HPV types covered by the vaccine.  
 Gardasil nine packs followed the same protocol of administration period as in 
Gardasil (quadrivalent) vaccine type (Lowes, 2014). Health care providers have not done 
a good job of encouraging and educating parents on present HPV vaccine; however, the 
new vaccine approval released on December 10, 2014 offered a more preventative 
measure. According to Lowes (2014), the vaccination was a critical public health 
measure “stated Midthun.” The vaccine helps to lower the risk of most cervical, genital, 
and anal cancer caused by HPV. The lack of HPV vaccine acceptance or uptake most 
likely increase HPV infection prevalence. The need for change indicated by the federal 
government goal planning to vaccinate 80% of boys and girls against HPV by the year 
2020. The federal goal is far higher than 38% girls and 14% boys who completed the 
three doses of HPV vaccine in 2013, as reported by National Immunization Survey data 






Educating parents on the importance of vaccination has become increasingly 
difficult in recent years due to antivaccine literature and negative media coverage. 
Parental inability to freely consent to HPV vaccine has been attributed to lack of 
knowledge and cynicism that their child or children are not sexually active and do not 
require HPV vaccination. Multiple researchers showed that parents’ lack of knowledge of 
HPV and HPV vaccine affects the rate of acceptance of HPV vaccine for their children 
ages 9 to 17 years. Research evidence has also demonstrated that an educational 
intervention increases the uptake of the HPV vaccine among the target population.  
Educational interventions for parents and patients (booklets and videos) have 
increased the HPV vaccination rates for children and adolescents (Fernandez, Allen, 
Mistry, & Kahn, 2010; Reiter, Stubbs, Panozzo, Whitesell, & Brewer, 2011; Krawczyk et 
al., 2012; Mayne et al., 2012; Wetzel et al., 2007). According to Krawczyk et al. there 
was a comprehensive HPV educational protocol information booklet containing a script 
for the clinicians available and a booklet for patients and their parents containing 
pictures, diagrams, and phrases. Mentioned in the booklet was the policy to increase 
educational efforts of the HPV vaccines acceptance as prerequisite for school entrance 
and immigration (Fernandez et al., 2010). The pre and post education PowerPoint 
presentation on HPV and HPV vaccine for school and healthcare staff serve as other 
identified best education practices (Reiter et al., 2011).  
The clinicians’ educational focus in the form of immunization alerts, education, 
and feedback built into electronic medical record (EMR) of the health information 
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technology (HIT) used in the primary care was another best practice approach that target 
clinicians and lead to increase in HPV vaccination. The utilization of the Radionovela, 
which was a sort of short stories in Spanish language for television, radio, and print 
developed through involvement of Latino community, to increase awareness of HPV and 
HPV vaccine. These short stories formed health promotion messages that targeted the 
Spanish-speaking community with low level of literacy (Kepka, Coronado, Rodriguez, 
&Thompson, 2011). Mayne et al. (2012) identified family focus educational interventions 
in which telephone reminder and voice messages utilized. Mayne et al. advocated 
direction to educational content inform of online educational materials or reminder to 
utilize pamphlet on HPV and HPV vaccines provided on clinic visit to serve as a guide in 
increasing HPV vaccination. 
Researchers have supported educational intervention regarding HPV acceptance 
thereby increase HPV vaccine uptakes are (CDC, 2014; Gonik, 2006; Kennedy, Sapsis, 
Stokley, Curtis, & Gust, 2011; Okoronkwo et al., 2012; Spleen, Klushman, Clark, 
Dignan, & Lengerich, 2012). There are many ways to provide the educational materials 
to the parents of studied population. The clinicians or health care providers should 
provide the necessary educational information related to HPV and HPV vaccine on an 
individual basis. The individualized education tailored according to the parent’s 
background, age, and educational level in order to yield needed intention of increasing 
HPV vaccine knowledge and HPV vaccine acceptance (Gonik, 2006).  
There was also a need for the strategies to increase the adolescent HPV vaccine 
coverage rate in the United States through the educational intervention provided for 
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patients and parents of the aforementioned age group population. Providers should also 
be encouraged to educate the parents of the population study group and make a strong 
recommendation during wellness visit. The most significant predictor of the HPV vaccine 
acceptance in clinical setting was through providers’ recommendation since parents trust 
their providers (CDC, 2014). All of these approaches are for the purpose of increasing 
HPV vaccination rate among the young adolescent. Spleen et al. utilized community-
based educational intervention to educate parents in Appalachian Pennsylvania in an 
effort to increase parental intent to vaccinate their daughters against HPV.  
The Appalachian community had a high incidence of cervical cancer and a high 
mortality rate. Okoronkwo et al. suggested a sustained educational campaign prior to the 
fall school start in Thunder-Bay, Canada. This campaign will offer a beneficial approach 
to increase the parental knowledge of HPV and HPV vaccine. Okoronkwo et al. believed 
that parental education supplied by a provider (physician) might also lead to an 
increasing number of parents to consent for their daughters for vaccination against HPV. 
Kennedy et al. adopted the CDC educational flyer targeted to the parents of adolescent 
girls and noted the increase in HPV vaccine knowledge and attitudes. The 
aforementioned also improve parental acceptance of HPV vaccine for their daughters. 
In regards to different educational approach based on different research studies, 
the most appropriate and less cost effective educational intervention was one-to-one 
individualized education based on the parental knowledge and behavior towards HPV 
and HPV vaccine. I repurposed the Kennedy et al. approach by utilizing an existing HPV 
pamphlet from the Patient Point fliers, from the Indiana government site and from CDC 
23 
 
site. There was no need to recreate the educational materials considering the time limit 
for the project. Apart from specific literature reviewed that targeted HPV and HPV 
vaccine and education, there was general that offers other information, such as the cause-
effect to HPV infection and HPV-related cancers. 
General Literature 
Researchers have addressed HPV ranging from various forms of cancers, such as 
cervical, anogenital cancer, and oropharyngeal, to genital warts and cancers (Dunne et al., 
2007). Epidemiology helped to uncover the relationship between HPV and cervical 
cancer. The first vaccine (Gardasil) was approved by the FDA on June 8, 2006 to prevent 
the four types of cervical cancer caused by an exposure to HPV. It was approved to be 
used in females aged 9 to 26 years (Friis & Sellers, 2014).  
HPV is the most common causative organism for cervical cancer worldwide. 
Cervical cancer is the third most common cancer in women in the world (Lee et al., 2013; 
Scarin et al., 2010). Cervical cancer was first in under-developed countries and third in 
United States following skin and breast cancer (Lee et al., 2013; Scarin et al., 2010). Lee 
et al. indicated that a healthy vaginal microbiota consists of lactic-acid producing bacteria 
known as Lactobacillus found in the vaginal epithelium. Lactobacillus is a normal flora 
that helps to maintain the low PH level of the vaginal wall. It helps to prevent the vaginal 
wall from being susceptible to the urogenital diseases. If there is any abnormality in 
microbiota, such as in the case of bacterial vaginosis (BV) thus leading to the increase in 
health risk of the upper genital tract, other health issues are miscarriages, recurrent 
abortion, preterm delivery, HPV infection, and other sexually transmitted disease 
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including HIV. However, normal host biochemical and immunological response to the 
microbiota is a healthy indicator of the vaginal environment that plays a protective role in 
women’s health (Lee et al., 2013). 
Cervical cancer has an increased burden in under developed countries as in 
Africa, Southeast Asia, Central, and South America. In United States, approximately 6.2 
million cases are documented annually. Out of these cases, 11,070 led to invasive 
cervical cancer. About 3870 death related cases reported annually (CDC, 2008; Hezog, 
Vallerie, Smith, & Wright, 2008; Scarinci et al., 2010). Oncogenic type of HPV affects 
quality of life, with significant financial implication (Herzog et al., 2008). There are 
notable quality of life changes in relation to the psychosocial effect of HPV infection 
such as in different emotional and mental health.  Such responses include but are not 
limited to depression, anxiety, anger, and relationship issues. Men also exhibit a higher 
level of stigma (Herzoget et al., 2008; Sandfort & Pleasant, 2009; Royer & Falk, 2012). 
Henderson et al. (2011) proposed that the provision of accurate and relevant information 
of the level of the protection HPV vaccine offers was very important in prevention of the 
HPV infection. Further education offered to the vaccinated girls to values the importance 
of cervical screening for additional protection against cervical cancer. 
According to Kevin (2006), the annual cost for cervical screening and HPV-
related cancer was about $26,415 per 1000 women. Two thirds of that $16,746 was 
attributed to routine screening. Each genital warts case has an average total cost of $436, 
with the total office visit average being three times with an annual cost of $1692 per 1000 
persons. About five cases per 1000 patients per year in men age 25 to 29 years cost of 
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$1717 (Kevin, 2006). Based on the analysis, an effective budget that would target recent 
and future care of the identified population is of paramount importance. The social 
agency (CFHC) resources forecasted the need for periodic review to provide better 
outcome of care that meet the need of identified population health. Herzog et al. showed 
that in the United States, the direct cost for cervical precancerous conditions in 2001 was 
about $3.6 billion, with an estimated annual cost in HPV related conditions between 2.3 
billion to 4.5 billion. The cost was even more significant in the developing countries due 
to the high incidence rate of cervical cancer. 
Improving vaccination coverage would be an important strategy to reduce the 
burden of cancer and diseases caused by HPV. Health education to improve the 
knowledge of HPV and HPV vaccines among parents and adolescent patients will 
increase the HPV vaccination acceptance rate. Individualized education intervention 
reduced the HPV prevalence and improve the HPV vaccine adoption (CDC, 2014; 
Herzog et al., 2008; Markowitz et al., 2014; Royer et al., 2012; Sandfort et al., 2009). A 
strong recommendation by the health care provider during a clinic visit notably increased 







Conceptual Models/Theoretical Frameworks 
The health issue of concern for the QI project was HPV infection and HPV 
vaccination within the targeted population being 9 to 17 years old. I provided the guided 
information that addressed the barriers to parental acceptance of HPV and the impact of 
the educational intervention through the application of theoretical frameworks and model. 
The theory appropriate for the study population health issue was TRA also known as 
TPB. The TRA or TPB assumes that individuals are rational and they must have a 
positive attitude toward change. The individual must have the feeling of control towards 
the change and that the changes are perceived as positive by their social group. The 
theory was widely used both nationally and internationally. Most groups accept it as a 
source of establishing changes in the parental beliefs, attitude, behavior, and the 
intentions leading to their behavioral performances (White & Dudley-Brown, 2012). 
The TRA or TPB came about in the late 1960s by Ajzen and Fishbein. The theory 
was used to explain the relationship among beliefs, attitudes, intentions, and behavior. 
Based on the theory, a person’s behavior is manifested as a result of their intention. 
According to social psychologist, intention is the cognitive representation of an 
individual’s readiness to perform a certain behavior (McEwen & Wills, 2011). The same 
are determined by the items below: 
1. The attitude toward the behavior, which is in the form of salient belief 




2. Subjective norm or normative beliefs, which mostly seen as a social and 
peer pressure. The kind of behavior projected to meet the other people 
expectation of an individual behavior in an attempt to comply with the 
wishes of the significant others.  
3. Perceived behavioral control is the perceived power of factors that may 
accelerate or impede the behavior.  
Overall, individual beliefs and intention affect their behavioral pattern. TRA or 
TPB typically utilized in nursing in the area of health promotion as in HPV population 
health problem. The theory can be used to educate parents to make them aware of HPV 
infection and its sequelae such as cervical cancer or genital warts. It can also be used to 
identify the need for the educational interventions that will lead to positive behavioral 
change and promote HPV vaccine acceptance (McEwen & Wills, 2011). The theory 
could be used to assess parental beliefs and intention to vaccinate their loved ones’ 
against HPV vaccine during undertaking of this project. 
Askelson et al. (2011) used TPB as a framework for their study because this 
framework helps to predict people intention to perform or engage in a specific behavior. 
The purpose of their study was to evaluate the physician/provider intention to discuss 
HPV vaccine since physician supported the vaccine due to its approval by professional 
organizations particularly ACIP and CDC. The providers that have the positive attitude, 
perceived willingness, and behavioral control towards HPV vaccine are more freely to 
have the greater intention to discuss with 9 to 15 years old females about sex in relation 
to HPV vaccination. Attitude, subjective norms, and perceived behavioral control 
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reported by Askelson et al. as important predictors of provider intention to discuss sex-
related topic to 9 to 15 years old female patients during vaccination against HPV. It was 
noted that HPV vaccine does provide an opportunity for the provider to discuss sex-
related issue to young female patients. In the past, providers have found it difficult to 
discuss sex-related issues with their young female’s patients. Recently, the need for HPV 
vaccination have improved the provider intent to talk about sex after administering the 
HPV vaccine (Askelson et al., 2011). 
Juraskova et al. (2012) did a meta-analysis of 161 studies utilizing TPB indicates 
attitudes, subjective norms, and perceived behavior control (PBC) accounted for 39% 
differences in intentions. With about 25% differences in the behavior, PBC shows the 
predictability of behavior alone over intention is about 2%. The purpose of the study was 
to explore the impact of the educational intervention in increasing vaccination 
intention/behavior. The TPB demonstrated efficacy application to the study by 
highlighting the importance of moral norms in the individual behavior such as in relation 
to the HPV vaccine acceptance. 
Roberto, Krieger, Katz, Goei, and Jain (2011) investigated the ability of TPB or 
TRA in predicting whether or not providers encouraging parents of the adolescent 
children allowed them to vaccinate against HPV. Adopted theory showed that attitudes 
and norms should be a target while dealing with the HPV topic and related population 
audience. Roberto et al. indicated that developing theory-based intervention using TRA 
or TPB should be excellent in facilitating providers to encourage the adolescents’ parents 
to vaccinate their daughters against HPV. 
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Walhart (2012) in a study of the parents, adolescent children, and the HPV 
vaccine used TPB and concluded that it is a common theoretical framework used in 
exploring parental beliefs about HPV vaccine. Walhart used a randomized nationwide 
population-based survey of 13946 parents (11187 are girl’s parents with 2759 of boy’s 
parents) in an attempt to investigate gender differences in relation to parental intention to 
vaccinate their adolescents’ with HPV vaccine. Walhart showed that about 70% of boys’ 
parents thought it was a good idea to vaccinate the girls while only 54% of girls’ parents 
thought it was necessary to immunize the boys. The result of the study was a proven 
source that could influence parental behavior in vaccinating their adolescent with HPV 
vaccine as a form of peer group pressure intervention. 
The TRA assumes individual are rational and connect the individual’s behavior to 
their beliefs, attitude and intentions, see below definitions and how it is linked in Figure 1 
in explaining its adaptive usage for the proposed HPV project. Behavior-a specific 
behavior that need to occur for individual to understand the need for action, for whom the 
action was directed to, when and where. Intention-is the best predictor that a behavior 
will occur which is influenced by attitude and norms. Attitude-the individual is positive 
or negative feelings in the process of performing the behavior. Norms-the individual’s 




Figure 1. Theory of Reasoned Action. From White, K. M. and Dudley-Brown, S. (2012). 
Translation of Evidence Into Practice. Reproduced with permission of Springer 









Believe about the outcome 
of the behavior. If I let my 
child receive HPV 
vaccine, my child will be 
healthy.  
Evaluation of expected 
outcome. Receiving 
HPV vaccine will 
prevent all HPV 
sequelae. 
Normative beliefs, 
based on education 
provided. I will let my 
child receive HPV 
vaccine. 
Motivation to comply. I 
want to follow the 
direction that the 
project programmer 









Pathman’s Pipeline Model 
I used information on the Pathman’s pipeline model as an evidence-based model 
to reduce the gap in HPV vaccine knowledge. Pathman, a pediatrician, in collaboration 
with Konrad, Freed, Freeman, and Koch in 1996, developed the model. They studied 
vaccine compliance and designed a multistage model for moving the evidence into 
practice while making sure the model support identification of factors that prevent 
utilization and adherence to the vaccination. The model composed of seven stages that 
involve evidence to action: awareness, acceptance, applicable, able, act on or adopt, 
agree, and adhere. Those facets are mostly what providers face when trying to help 
parents understand and accept the HPV vaccine. Incorporating the Pathman’s pipeline 
model with TRA or TPB assisted in recognizing health promotion strategies as a provider 
and project planner, while at the same time addressing parental issues related to the HPV 
vaccine acceptance.  
This ensured the right path to the identified population optimal health outcomes, 
as well as moving from evidence to practice (White & Dudley-Brown, 2012). Both the 
theoretical framework and model have showed different utilization and effectiveness in 
addressing HPV health population issue in the identified population from the past 
research studies. Although Pathman’s pipeline model have not been effectively used in 
many research studies, barriers to new knowledge development and implementation can 
occur at any stage of the seven steps in the process. For the purpose of this developmental 
project, I focused on four out of the seven facets in the process: acceptance, awareness, 
adhere, and agree. The application of the stages by the project development team ensure 
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that parents receive the necessary educational support that leading to an awareness of 
HPV infection and available HPV vaccine. Also, encouraging the parents to agree to the 
provided information, facilitate the acceptance of HPV vaccine, and encourage adhering 
to the process involved in completing the three doses that offered the protection for the 
identified population against HPV. In this proposed developmental project, I may be 
among the first to use Pathman’s pipeline model in addressing the impact of an 
















Figure 2. Pathman’s Pipeline Model. From White, K. M. and Dudley-Brown, S. (2012). 
Translation of Evidence Into Practice. Reproduced with permission of Springer 





Different research articles related 
to HPV and HPV vaccine. This 
will enable the provision of the 
appropriate information to the 
parents.  
Parental awareness and 
knowledge improvement related 
to HPV and HPV vaccine 
through educational intervention 
Provide different 
educational information in 
the form of pamphlets and 
flyers to inform parents of 
HPV and HPV vaccine. 
Parents based on 
educational knowledge 
provided consent to give 








Section 2 focused on reviewed of different scholarly research articles. The 
specific literature review that informed the project through details explanation of HPV, 
HPV vaccine, and different educational interventions used in the past. The general 
literature review will have impact on the general aspect of the project such as the effect of 
HPV as in cervical cancers, oropharyngeal cancers, anal cancers, and genital warts. 
Despite different research articles on HPV and HPV vaccine, there still existing 
significant gap in literature that targeted by a unified educational intervention. Consistent 
and unified educational intervention thus adequately impacted parental decisions to have 
their children ages 9 to 17 given the HPV vaccine. 
Section 3 was a description of the approach to the proposed QI initiative to 
develop an educational intervention that increased the parental decision to have their 
children vaccinated against HPV at CFHC. The section also covered the details regarding 
the project development including review of already available educative materials with 
the clinic providers, the targeted population identification, Institutional Review Board 
approval and the plans for implementation and evaluation.  
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Section 3: Methodology 
Introduction 
The purpose of this proposed QI project was to develop an educational 
intervention and implementation plan utilizing existing information from the CDC, 
vaccinate Indiana government sites and Patient Point (PP). The implementation and 
evaluation plan developed with the organization mission and values in mind by the 
collaborative team. This section was an outline of the strategies used in the project 
development and a description of the process in which the planned educational 
intervention implemented and evaluated. Figure 3 was the Gantt chart timetable.  
1. Put together collaborative project team of the clinic providers 
2. Discuss with the team the relevant evidence and literatures that support the 
proposed developmental project 
3. Review with the team the already existing educational intervention that  
informed the project 
4. Obtain validation using experts in the filed for the proposed project 
questions in the form of parental assessment tools  















Figure 3. Gantt chart with Project timeline. 
Interdisciplinary Project Team 
The collaborative team members for the proposed developmental project utilized 
TRA or TPB as the framework and Pathman’s pipeline model in addressing the plan 
project question. This social psychology theory could be used during this proposed 
project development to change unhealthy behavior to healthy behavior (McEwen & 
Wills, 2011). The team members who are mainly the clinic providers will also utilized the 
educational intervention proposed for the project planned through printed educational 
material (pamphlet and flyer) as indicated in Appendix C. Face-to-face interaction and 
education in relation to HPV and HPV vaccine and answering patient questions and 
concerns during the clinic visit of the studied population will serve as another mode of 
delivering planned education to the parents.  
TRA or TPB could also be used to address the parents of studied population 
directly in one to one counseling or educational section. TRA or TPB used during the 
proposed project development will ensure the promotion of healthy behavior. The theory 
could be used to promote the people awareness of health problems with the proposal of 
positive behavioral change (McEwen & Wills, 2011). The theory was used in the 
majority of nursing research studies, most importantly in the provision of an educational 
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intervention that informed HPV and HPV vaccine as mentioned in section two of the 
project. This would be accomplished with the use of validated questionnaire in the form 
of parental assessment tools in Appendix B. 
Pathman’s pipeline model would help to identify factors that promote adherence 
and utilize on individual basis during one to one parental discussion for the proposed 
project. The model will be used during the proposed project to observe the leak in 
parental knowledge or barriers to the implementation of new knowledge and how to 
breakdown those barriers (White & Dudley-Brown, 2013). The model will help to 
provide the strategies needed during the proposed plan implementation of the educational 
intervention that would ensure sustainability of the project. 
Review Evidence 
Researchers of HPV in the past have mostly used the cross-sectional study for the 
design of their population study. For the purpose of this QI project, there would be a 
variety of activities involved in order to ensure the educational intervention strategies 
would target the identified population. In the guidance for health economics study 
presented to Advisory Committee on Immunization Practices (ACIP), different methods  
employed to ensure the intervention strategies are identified and described with a baseline 
included. The cost values and resources are incorporated into the program, with both 
direct and indirect medical and nonmedical cost of immunization in reasonable 
perspective were presented to the ACIP by the programmer. The economic model used 
cost-benefit, cost-effectiveness, and cost analysis that covered all the diverse vaccine-
related issues to enable ACIP to understand the purpose of the program (Lieu, Meltzer, & 
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Messonnier, 2007). The committee ensures that the cost effectiveness of the vaccine was 
directly proportional to the outcome effect of the vaccine prior to the presentation to 
ACIP. The proposed developmental project will utilize the rational planning model 
similar to the above model used by Lieu et al. The rational planning model tied the 
resources to the program goals and objectives. It also utilizes available data in the 
decision-making process to ensure the successful outcome of the program (Kettner, 
Moroney, & Martin, 2013).  
Population and Sampling 
The proposed sample characteristics for the QI project are parents of 9 to 17 year 
old children who are yet to complete or initiated the three series of HPV vaccine at 
CFHC. The sample populations will include all ethnic groups that meet the age criteria 
and attend CFHC for their wellness visit. The CFHC policy was not to immunize children 
when they are running fever or on antibiotics and the proposed project would follow the 
same protocol. 
Ethical Considerations 
The ethical consideration involves in the proposed QI project followed by 
submitting all the necessary paperwork to obtain approval from Walden University 
Institutional Review Board (IRB) prior to developing an Educational Intervention to 
Impact on Parents’ Decision to have their Children ages 9 to 17 given the HPV vaccine.  
Permission to use all diagrams as in TRA or TPB and Pathman’s pipeline model, and PP 




Develop Implementation Plan 
The development of the implementation plan will transpire with the project team 
leader in communication with the collaborative team members.  
1. Baseline data for this QI project will be collected to determine the pre 
acceptance rate of HPV vaccination among the parents’ of the studied 
population.  
2. Due to the cost of treating the HPV related conditions, the financial 
implications of the project need consideration during the proposed project 
development. 
3. No separate budgeting available for the proposed project since no new 
wheel created regarding the educational materials.  
4. The proposed QI project was a cost effective project and uses available 
resources and activities to improve the existing service while promoting 
parental better understanding of HPV and HPV vaccine.  
The proposed project had all the necessary resources within the clinic system. 
There are easy printing access of the flyers, the pamphlet from PP, CDC site, and 
vaccinate Indiana government site with no additional cost to the clinic. When parents 
accept to vaccinate their children for HPV vaccine based on knowledge improvement, the 
vaccine was readily available through Vaccine for Children Program (VFC). Majority of 




Develop Evaluation Plan 
Program evaluation was the most important of the program and must be a 
continuous or ongoing process. The evaluation activities and the derived information 
must be significant and useful to the program planner, the clinic staff, and the targeted 
population studied (Hodges & Videto, 2011). The evaluation helps the collaborative team 
to revisit the project strategies effectively for better program outcome. The initial plan 
would be meeting with the collaborative team member such as the clinic owner, manager, 
health care providers, the parents of the identified population, and other clinic supporting 
staff members. It will be an ongoing process throughout the proposed plan program 
evaluation, in ensuring everyone is well informed and that the program is leaning towards 
meeting its goal and objectives. 
The collaborative team have the options of utilizing the validated questionnaire to 
the parents’ of  the proposed studied population in the form of parental assessment tools 
(Appendix C). The patient and the public want to involve in their health care and 
treatment decisions (McKennah, Keeney, & Hasson, 2009). Additional plan proposed 
educational intervetion inform of face-to-face discussion and distribution of free 
pamphlet from PP, flyers copied from vaccinate Indiana government sites and the CDC. 
The educational materials will inform parents’ of HPV and HPV vaccine, for the purpose 
of targeting their behavior and improving their knowledge.  
There are four stages of evaluation: formative, process, impact, and outcome 
evaluation (Friis & Sellers, 2014). Formative evaluation is a type of evaluation adopted 
early in the program as soon as the program conceived. It helps to ensure all forms of 
41 
 
activities, materials, procedures, plans, and modifications during the implementation of 
the program work. Process evaluation involves describing, monitoring, and documenting 
the organization and program-related issues in order for the program planner to improve 
effectively, the proposed program and provide support for the program. It will also ensure 
theories and model applied in accordance to the goal and objectives of the proposed 
program.  
Process evaluation allows for charting progress review in ensuring meeting the 
goals and objectives of the proposed developmental plan program. Resource evaluation 
was conducted, which includes budget review and assessment of training provided to the 
staff. Investigating the process in place to ensure time allotted to implement and conduct 
the program activities were sufficient was also a necessary part of the proposed project 
evaluation (Hodges & Videto, 2011). The purpose of the outcome evaluation was to 
measure how well the program meets its intended long-term goal. The proposed plan 
evaluation will also measures the impact of the program on health status changes or 
quality of life improvement. 
The proposed quality improvement project will use impact evaluation. Impact 
evaluation determines changes in program participants instead of the organizations or the 
communities. Impact evaluation seeks to answer the program plan design questions. The 
purpose of impact evaluation was attempting to see if the program has an impact and 
provide a positive outcomes or program results. The proposed plan impact evaluation 
also aims to establish a cause and effect relationship between a program and its outcome 
(Hodges & Videto, 2011). The proposed plan impact evaluation will be used to examine 
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the improvement in behavior, environment, predisposing, reinforcement, and enabling 
factors based on goals and objective of the developmental program ( Hodges & Videto, 
2011).  
Overview or final evaluation of the proposed plan project development will help 
to provide the information on what works and what did not work during the plan project 
implementation. I proposed utilization of cause and effect impact of education to the 
collaborative team during the proposed project development phase which measure based 
on looking at the pre HPVvaccination rate prior education intervention and post effect of 
education on the HPV vaccination rate. The proposed project will also compare the pre 
and post impact of educational intervention on parents’ decision to have their children 
ages 9 to 17 given human papillomavirus vaccine results that will be shared with the 
social agent stakeholders. 
Table 2 
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and HPV vaccine. 
Parental knowledge 
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The parental lack of knowledge, attitudes, and behavior towards HPV and HPV 
vaccine best addressed through a planned educational intervention. The proposed plan 
educational intervention will create the parental awareness of HPV and HPV vaccine. 
The proposed plan implementation of an educational intervention project would provide 
opportunity for the change in the clinical practice thereby, increase parents’ decision to 
have their children ages 9 to 17 given human papillomavirus vaccine. The educational 
strategies for the proposed project would lead to increase acceptance of the HPV vaccine 
and promote wellness. This developmental project proposal has been reviewed and 
approved by the Walden University IRB with the approval number (07-08-15-0469221). 
Overall, Section 3 of the proposed QI project focused on how the project developed, how 
the proposed project implemented, and the data collection to allow for evaluation of the 




Section 4: Findings, Discussion, and Implications 
Summary of Findings 
 The purpose and the main objective of this proposed QI project was to develop an 
educational intervention to increase the uptake of the HPV vaccine at the study clinic in 
Lake County Indiana. Since, this was a developmental project, it allows for dialogue 
within the collaborative team as to how the project could be fully implemented and 
evaluated in future utilizing already available resources within the organization as 
indicated in (Appendices C and D). This developmental project does not involved pilot 
study since HPV vaccine always made available to the patient but the acceptance rate was 
an issue that led to low uptake at the study clinic. In bridging the gap in practice, the 
discussion emerged with the collaborative team member involvement in designing 
parental education intervention that would improve the HPV vaccine acceptance rate. By 
following the guidelines stipulated in this developmental QI project, the study clinic will 
be able to implement the educational intervention as developed in meeting the Federal 
goal of vaccinating 80% of boys and girls against HPV by 2020 (McCabe, 2014). 
 Since the project was at the developmental stage, there were no study findings or 
corresponding supporting research literature to support further project discussions. This 
section was a further exploration of the development of an anticipated project strengths, 
limitations and recommendations. In addition, potential implication for policy, practice, 




 This quality improvement project explored and document anticipated 
developmental project strength, limitations and recommendation as a guidance for the 
collaborative team. Program implementation could be daunting, even the best program if 
not structured to the audience does not always work. Since the major barrier to 
acceptance and uptake of the HPV vaccine was parental lack of education. It has been 
noted that sometimes, it is not the same group of people that plan and develop a program 
that implement them. For that same reason, the program must be tailored to the intending 
audience in order to meet the objective for adoption, implementation and sustainability 
(Hodges & Videto, 2011). 
Policy Impact 
As an advanced nurse practitioner, I believed the health care group cannot 
practice in isolation. Due to the rising cost of health care, there was a need for health care 
providers training to add a population orientation to their current role of caring for 
individuals in their various areas of practice (Bodenheimer & Grumbach, 2012).  During 
this project development, I conducted a word format interview with the Director of 
Immunization in the State of Indiana. During the process, I was able to realize the low 
rate of acceptance of HPV vaccines in the State. Despite the global consensus on which 
vaccines generally offered benefits that outweigh the risk and strong cost-effectiveness, 
recommendation for specific vaccine usage and priority for targeted group for national 
immunization programs are still inconsistent across countries (Nieburg & McLaren, 
2011). The proposed project development if implemented will be used to influence policy 
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and policy makers by providing well prepared information to the health care core players; 
familiarizing and utilizing core positions and networking; identify and team up with other 
nurses in influential position outside the nursing profession; and communicating one’s 
standing on issues through appropriate strategies (Hewison, 2007). The primary goal of 
this developmental QI project was to follow the principle of risk-benefit analysis as part 
of health care decisions and recommendations in keeping the patient safe, while at the 
same time providing best outcome of care to the consumer of healthcare (Zaccagnini & 
White, 2011).  
Clinical Practice 
Bridging the gap in practice initiate the discussion within the team members that 
led to the development of this QI project in the form of an educational intervention to 
impact on parents decision to have their children ages 9 to 17 given the Human 
Papillomavirus Vaccine. Advanced knowledge by the nurse providers provides an array 
of opportunity for new knowledge and translation of the knowledge quickly and 
efficiently to the benefit of the patients in their daily demands practice environments 
(AACN, 2006).  I have noted through different research studies that parental decisions 
not to consent to the HPV vaccine was due to a lack of knowledge, behavior, attitude, and 
their belief that their child or children are not sexually active and does not required HPV 
vaccination (Thomas, Strickland, DiClemente, Higgins, & Habber, 2012; Walhart, 2012).  
It was reported that educational interventions enhance parental HPV knowledge and 
vaccination intentions thereby increasing HPV vaccination rates (Krawczyk et al., 2012). 
Evidence showed the most significant predictor of the HPV vaccine acceptance in clinical 
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setting was through provider recommendation since parents trust their provider (CDC, 
2014). Clinical practice would benefit from this developmental project if properly 
implemented utilizing available educational resources and developed project questions in 
the form of parental assessment tool thereby, leading to increasing rates of human 
papillomavirus vaccine uptake.  
Research 
Chang, Russell and Jones (2010) identified in their study, time as one of the 
barriers why nurses were unable to widely adopt evidence-based practice (EBP). 
However, clinician guided education promote parental HPV acceptance especially if it is 
individualized based on parental background, age, and educational level (Gonik, 2006). 
Despite various research evidence on parental educational intervention there was no 
direct assessment tool to inform the project. The expert validated developed project 
questions in the form of parental assessment tool during this QI project development, if 
well implemented may support future research studies by answering the following 
questions such as: 
• Thus improving or changing parents of 9-17 years old involved in the 
study beliefs against HPV and HPV vaccine affect HPV vaccine uptake?  
• Thus improve the acceptance of HPV vaccine thereby reducing the effects 
of HPV infection on the studied population such as (genital and anal 
warts, oral, cervical and anal cancer)?  
• Would the successful program integration and implementation impact 




Educational intervention improved parental barriers to acceptance of HPV 
vaccine thereby increase HPV vaccine uptake (CDC, 2014; Gonik, 2006; Kennedy, 
Sapsis, Stokley, Curtis, & Gust, 2011; Okoronkwo et al., 2012; Spleen, Klushman, Clark, 
Dignan, & Lengerich, 2012). It was discovered during the developmental project that 
most parent has barriers such as: lack of knowledge of HPV vaccine and beliefs that their 
children are too young to engage in sexual activities (Thomas et al., 2012; Walhart, 
2012). According to Kotter, understanding change takes a long time thus improve 
chances of success. Sharing of the proposed educational intervention that would increase 
parental knowledge of HPV and HPV vaccine was the primary focus for this 
developmental project. Patients have entrusted their care in our hands; nurses should 
maintain the knowledge and integrity while partnership with other healthcare groups in 
ensuring safe, cost-effective, outcomes of care for the patients. Parents needed education 
in order to meet the goal of the federal government that is to vaccinate 80% of boys and 







Project Strengths, Limitations, and Recommendations 
Project Strengths 
The strength for this developmental project would be effective communication 
within the collaborative team. According to Covey (2003), whether someone is writing or 
providing information to others, all are forms of communication. Same are speaking and 
listening to what others have to say. We communicate almost every minute in our day-to-
day activities. For effective project implementation and evaluation, the team members 
must be able to communicate and ready to work with one another’s (teamwork) to ensure 
the success of the proposed developmental project. It was imperative as a collaborative 
team to communicate efficiently in order to disseminating new initiatives and innovations 
in clinical practice as well as research findings and other ideas in nursing to bridge the 
gap in practice (Oermann & Hays, 2011). Utilization of the proposed project questions in 
the form of parental assessment tool will serve as a guide to parental education to 
improve parental acceptance of HPV vaccine and increase HPV uptake 
Project Limitations 
Despite the fact that this proposed developmental project generate discussion in 
relation to an educational intervention that would promote parental acceptance of HPV 
vaccine, the main limitation of the project was that it has not been fully implemented. 
Presently, there is no opportunity for me, to statistically evaluate the outcomes of the 
educational intervention. I was limited in the terms of the literature targeting males 
during the time of the project development. Time allocated to the providers during patient 
wellness visit and stakeholders’ involvement anticipated to be the barrier that may limit 
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the sustainability of the project. According to Miake-Lye et al. (2011), their evidenced-
based project seemed feasible in the beginning and went through multiple changes, but 
unable to sustain the project due to lack of leadership involvement and staff commitment. 
I am employed at the study clinic at the time of the initiation of the proposed QI project. I 
developed the proposed project questions in the form of parental assessment tools 
(Appendix C) which was validated by the experts in the field. This could create bias and 
limit the tool validity and generalization of the study (Terry, 2012) 
Limitation Recommendations 
Since there was no pilot study, as the project developer, I was limited in this 
project recommendation. For the future evidence-based project implementation, will 
anticipate the barriers above at the inception of the project and incorporate needed 










Analysis of self 
Scholar 
The DNP program has provided me the opportunity to develop and evaluate 
healthcare delivery approaches that meet the current, future, and daily prospective needs 
of the patient populace in references to evidence-based research findings in nursing, other 
clinical sciences, organizational, political and economic sciences (AACN, 2006). The 
DNP journey has afforded me the opportunity in identifying practice gap and developed 
different evidence-based project through the practicum experiences incorporated into the 
program, leading into the enhancement of knowledge to improve nursing practice, and 
patient outcomes (Terry, 2012). In conjunction with various evidence-based research that 
support this developmental project, its approval facilitated my scholarship of practice in 
nursing (AACN, 2006). The scholarship of discovery through evidence-based research, 
integration and application of the discovered knowledge has helped me in this 
developmental project, which if implemented successfully would help to guide 
improvements in the clinical practice and patient outcome of care. 
Practitioner 
As an advanced practitioner, the DNP program has afforded me an array of 
opportunities in the following areas, such as: quality improvement strategies, 
collaborating with others in various practice management based on professional standard, 
political skills, and utilization of principles of economics and finance to redesign cost 
effective care without jeopardizing the provision of quality care (AACN, 2006). 
Healthcare delivery is currently at its fast pace, lack of effective education to parents of 
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ages 9-17 years in relation to HPV infection and available HPV vaccine will increase 
HPV infection rate and reduce HPV uptake thereby increase cost of healthcare. In the 
spirit of common good as justification for access to healthcare, effective implementation 
of the developed expert validated project questions in the form of parental assessment 
tool, I developed to provide an educational intervention to the parents’ of the children 
ages 9 to 17 years would improve the uptake of HPV vaccine and reduce the cost of HPV 
sequelae. 
Project Developer 
This developmental project proposal has gone through a lot of scholarly review 
and recommendations. The process afforded me the opportunity to understand the process 
involved in designing and managing a program. As the project developer, the ability to 
identify the goals and objectives of the planned project with the thoughtful 
implementation and evaluation plan as in the impact evaluation for this project proposal 
would enhance the project successful implementation and sustainability (Kettner, 
Moroney, & Martin, 2013). Developing this proposal that received IRB approval involves 
collaborative team effort, effective communication strategies that is an attributes to 






Project Contribution for Future Professional Development 
The emergent of this developmental QI project has inversely contributed to my 
clinical knowledge, advancement in practice and professional development. The 
knowledge gained through the evidence-based research gave me the opportunity to 
developed intervention that would bridge the gap in clinical practice. Despite the fact that 
this proposal was in its developmental stage, effective utilization of the educational 
intervention materials and the expert validated proposed project questions in the form of 
parental assessment tool will assist the provider in gaining parental acceptance of HPV 
vaccine thereby increase HPV vaccine uptake. 
Summary and Conclusions 
 The DNP developmental proposal as a form of QI project was to promulgate into 
the clinical setting a form of an educational intervention to impact on parents’ decision to 
have their children ages 9 to 17 given the HPV vaccine. There are multiple evidence-
based research efforts in favor of girls’ within the studied population age group than the 
boys. The federal target goals is to immunize 80% of both boys and girls by the year 
2020 in the U.S with the HPV vaccine (McCabe, 2014). 
 This developmental QI project addressed issues related to low acceptance of HPV 
vaccine and the educational intervention proposed to improve HPV acceptance and HPV 
vaccine uptake. It has been noted through different research studies that parental 
decisions not to consent to the HPV vaccine was due to lack of knowledge, behavior, 
attitude, and their belief that their child or children are not sexually active and do not 
require HPV vaccination (Thomas et al., 2012; Walhart, 2012). The anti-vaccine 
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campaign in the media that discourages most parents’ to vaccinate their children against 
HPV vaccine. Due to the above reasons, this developmental project reviewed different 
available evidence-based resources to provide parental educational intervention that 
would improve acceptance and increase HPV vaccine uptake. An educational 
intervention improved parental barriers to acceptance of HPV vaccine thereby increase 
HPV vaccine uptake (CDC, 2014; Gonik, 2006; Kennedy et al., 2011; Okoronkwo et al., 
2012; & Spleen et al., 2012). Research evidence shows that clinician guided education 
promote parental HPV acceptance especially if individualized based on parental 
background, age, and educational level (Gonik, 2006). 
 The developmental educational intervention will utilize the already existing 
educational resources as indicated in (Appendix D) in providing the necessary 
educational intervention to the parents of the studied population. The expert validated 
proposed project questions in form of parental assessment tool would be utilized by the 
providers in tailoring the individualized parental education. The subsequent or final 







Section 5: Scholarly Product  
Introduction 
The DNP developmental QI project was initiated to investigate and provide 
necessary information that led to the initiation of an educational intervention to impact on 
parents’ decision to have their children ages 9 to 17 given the HPV vaccine through 
collaborative team effort. For this scholarly product to emerge, assessment was 
conducted that led to an evolution of a practice gap requiring planning that involves 
research evidence for practice through effective dissemination of identifiable evidence to 
improve healthcare outcomes (AACN, 2006). DNP prepared providers are expected to 
“translate knowledge quickly and effectively to benefit patients in the daily demands of 
practice environments”, for this reason, impact program evaluation was incorporated into 
this developmental project from the inception of the project proposal (AACN, 2006, pp. 
9). This section of the developmental QI project further examined the project 
background, recommendations for future project study, dissemination plan and 









HPV is the most common sexually transmitted infection worldwide (Drewry, 
Garces-Palacio, & Scarinci, 2010; Palli, Mehta, & Aparasu, 2012; Walhart, 2012) 
In the United States, HPV is the most commonly transmitted sexual infection with the 
overall infection prevalence showed that about 20-79 million people currently infected 
with HPV. About 6.2 million between the ages of 14 to 44 years are affected annually 
(Cates, Ortiz, Shafer, Romocki, & Coyne-Beasley, 2012; CDC, 2014; Dunne et al., 2007; 
Gamble, Klosky, Parra, & Randolph, 2010; Oldach & Katz, 2012; Sussman et al., 2007; 
Thomas, 2008; Yitalo, Lee, & Mehta, 2013).  
Educational interventions have been a proven strategy demonstrated through 
different evidence-based research studies leading to improve parental acceptance of the 
HPV vaccine thereby increasing HPV vaccine uptake (CDC, 2014; Gonik, 2006; 
Kennedy et al., 2011; Okoronkwo et al., 2012; & Spleen et al., 2012).  This 
developmental proposed QI project also utilized TRA or TPB to address the parents of 
studied population directly in one to one counseling or educational section. The theory 
utilized to promote the parental awareness of health problems with the proposal of 
positive behavioral change (McEwen & Wills, 2011). Pathman’s pipeline model would 
help to identify factors that promote adherence and utilize on individual basis during one 
to one parental discussion for the proposed project. The model used during the proposed 
project to observe the leak in parental knowledge or barriers to the implementation of 
new knowledge and how to breakdown those barriers (White & Dudley-Brown, 2013). 
The theory and the model application will help to provide the strategies needed during the 
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proposed planned implementation. The educational intervention will improve parental 
knowledge and increase acceptance of the HPV vaccine thereby increase HPV vaccine 
uptake. 
Patients trust their providers. As a result, research studies confirmed that clinician 
guided education to promote parental HPV acceptance especially if individualized and 
tailored based on parental background, age, and educational level will work (Gonik, 
2006). Providers effectively utilizing the expert validated proposed project questions in 
the form of parental assessment tools would serve as a base for educational intervention, 
anticipating improvement and increase in the HPV vaccination rate within the studied age 
range population. 
Proposal and Future Project Strengths 
 This proposal strength originates from the team approach, which provides 
effective communication strategies that led to the approval of an educational intervention 
to impact parents’ decision to have their children ages 9 to 17 given the HPV vaccine. 
There is a need for more research targeting males of the studied population. This project 
utilizes existing educational intervention materials to promote parental understanding of 
the HPV infection and the available HPV vaccine. Effective utilization of the expert 
validated project questions inform of parental tool assessment may afford the provider 





Recommendations for Future Project Study 
This was a developmental project with limited parental assessment tools based on 
the research, as a result, the clinic providers are encouraged to utilize the proposed expert 
validated project questions in the form of parental assessment tool in (Appendix C) to 
evaluate parental knowledge of HPV and HPV vaccine prior educational intervention 
implementation. Utilization of all the available educational resources as in (Appendix D) 
will be incorporated to provide safe and cost-effective care (AACN, 2006). There was 
limited research evidence focusing specifically on boys in the studied population, as a 
result future research study of on the impact on boys is recommended for generalization 
and global utilization.  
Dissemination Plan 
Dissemination serves as a final stage of research study which involves “diffusion 
or communication of research findings by presentation and publications to variety of 
audiences, such as nurses, other health professionals, policy developers and consumers” 
(Grove, Burns & Gray, 2013, p. 692). The major goal of any DNP project is to utilize the 
findings to improve practice thereby improving health outcomes. The goal is achievable 
only through effective dissemination of the project findings. The topic of my DNP project 
was providing parental education to impact the decision of parents to consent to giving 
children 9 to 17 years of age the HPV Vaccine.  
According to Zaccagnini and White (2011), there are many approaches that may 
be used to disseminate project findings.  Many are similar to dissemination of research 
such as publication in a journal.  Some may be personally advantageous to the author.  
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The author must consider the timeline from the submission to the publication and 
dissemination as this will affect the utilization of the essential evidence-based findings 
into practice. Podium or poster presentations, Internet webinar sessions, and media 
communications in form of YouTube, and journal clubs allows for dialogue and may be 
viewed for a longer time compared to a poster presentation by the targeted audience 
which may only be available for months. Poster presentations may be very useful in 
academic settings. Community presentations are another forum for disseminating 
research. Whichever forum is utilized, the targeted audience must be considered.  
Poster Board Presentation 
In the case of this developmental project in which the targeted audience is parents 
with various educational and ethical backgrounds, a poster presentation would be more 
valuable with handouts to further buttress and clarify the ideas on the poster.  According 
to Hand (2010), the poster is less stressful in terms of anxiety involved compared to the 
oral presentation. Posters, if meticulously prepared, provide an excellent means for 
dissemination of the evidence-based project. In addition, since the information on posters 
is limited it affords the presenter the opportunity to engage with the interested audience.   
The strengths of a poster presentation are: 1) allows sharing of information in a 
concise storyboard manner; 2) serves as a means of communicating information to 
interested parties while the project is still in progress; 3) allows for one-to-one dialogue 
between the presenters and the interested viewer, thus provide opportunity to ask 
questions from the poster presenters and the viewer to take informed information back to 
their various workplaces to further disseminate the EBP; 4) serves as a means of small 
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group discussion while disseminating the current EBP in a non-threating atmosphere that 
allows for active participation and learning (Forsyth, Wright, Scherb, & Gaspar, 2010). 
The quality and design, when properly combined in a poster, could serve as a catalyst for 
effective dissemination of the project findings to colleague and other targeted audience 
(Forsyth et al., 2010).   
Publication Aspiration 
DNP project was a form of quality improvement project to bridge the gap in 
practice while at the same time implementing a new way of doing things through 
evidence-based practice for a better outcome of care. As a scholar-practitioner and a 
nurse leader, developing the project without dissemination would not fulfill the purpose 
of the DNP program. As a member of the Sigma Theta Tau International, I will use my 
membership opportunity to request information on how to prepare and submit my 
developmental project abstract for review in obtaining access for publication. I would 
also explore other journal publication options as the project evolves. Apart from the 
poster presentation, my plan is to further disseminate this developmental project in the 
form of a strategy that the providers can use to provide an educational intervention to 
improve patient acceptance of the HPV vaccine thereby increasing HPV vaccine uptake. 
This could be achievable through podium presentations via my professional organization 
such as the Society of Nurse in Advance Practice (SNAP) and National Conference for 
Nurse Practitioner in the organization’s annual conference (NCNP). A scholar-
practitioner serves as a skilled and knowledgeable individual who is very proficient in 
quality improvement strategies and helps in creating and sustaining changes at the 
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organizational and policy levels through dissemination of evidence-based findings 
(AACN, 2006). 
Conclusion 
The dissemination of the scholarly project goes beyond the requirement of the 
DNP degree only, instead it serves as a means of integrating and applying evidence-based 
research and tools to improve the outcomes of care delivery by the advanced practice 
providers at the clinical practice level (Zaccagnini & White, 2011). I have been 
committed to this developmental QI project in ensuring an educational intervention that 
would promote parental acceptance of the HPV vaccine. This can be accomplish through 
collaborative teamwork, effective communication, and dissemination of the evidence-
based research to the clinical practice. The scholastic integration and application of the 
educational intervention would reduce cost of HPV sequelae and improve patient health 
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Appendix C: Proposed Project Questions in the form of Parental Assessment tools 
Human Papillomavirus (HPV) Proposed Vaccine Project Questionnaire 
Instructions: To be filled out by parent/guardian with the help of the clinic staff as 




Gender of the child 
o Male 
o Female 
Indicate age of the child ________________ 
 
Number of children in household _________________ 
 
Level of parental/Guardian education completed___________________ 
 
Yearly Household Income  
 
o Less than $19,500 
o $19,501 – $29,999  
o $30,000 – $50,000 
o Greater than $50,000 
 
Insurance Provider  
 
o Private  
o Public 
o Self-Pay 
o No insurance 
 
Race of the participant 
 




o Caucasian (White) 
o Other 
 











Parental/Guardian knowledge of HPV/HPV vaccine 
 
Circle the answer of your choice. 
1. My child may contact HPV and not know it.    
Yes  No  Not Sure                
2. My child can be infected with HPV through sexual act.          
Yes  No  Not Sure  
3. HPV infection can lead to cervical cancer.     
Yes  No  Not Sure              
4. HPV can spread through skin to skin contact.   
Yes  No  Not Sure         
5. HPV vaccine prevents against all types of sexually transmitted infections (STIs).  
Yes  No  Not Sure                              
6. People who received HPV vaccine do not have to use the condom during sexual 
intercourse.   
Yes  No  Not Sure  





 Change in parental attitude and increase knowledge of HPV/HPV vaccine  
 
Circle the answer of your choice. 
 
1. It is important my child receive HPV vaccine prior being sexually active. 
Yes  No  Not Sure                                                                
2. It will be beneficial for my child health if vaccinated with HPV vaccine. 
Yes  No  Not Sure  
3. HPV vaccine is being adopted to make money for drug companies.  
Yes  No  Not Sure  
4. I think the HPV vaccine is safe.  
Yes  No  Not Sure                               
5. My child is too young to receive a vaccine for STI as in HPV.  
Yes  No  Not Sure         
6. The vaccine is not effective in preventing cervical cancer or genital warts. 
Yes  No  Not Sure  
7. If my child receives HPV vaccine, it will be a license to involve in sexual activity.  
Yes  No  Not Sure  
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Questionnaire was developed and validated by experts in the field (The student, the 
preceptor, NPs in the office, including Dr. Omar Sheriff (clinic manager). 
 
Cuestionario de proyecto de vacuna virus del papiloma humano (VPH) 
 
Instrucciones : Para ser llenado por el padre/tutor con la ayuda del personal de la clínica 








Indicar la edad de la niña _______ 
 
Número de niños en hogares ______ 
 
Nivel de completed ________ de Educación de los padres/tutores 
 
Ingreso anual  
 
o Menos de $19.500 
o $19.501 – $29.999 
o $30.000 – $50.000 
o Más de $50.000 
 





o Sin seguro 
 
Carrera del participante 
  






o Caucásico (blanco) 
o Otros 
 




 Conocimiento de los padres/tutores de la vacuna contra HPV/VPH 
  
Círculo de la respuesta de su elección. 
1. Mi hijo puede contactar con VPH y no saben lo. 
 Sí   No  No estoy seguro 
2. Mi hijo puede estar infectado con HPV a través del acto sexual. 
 Sí   No  No estoy seguro 
3. Infección con el VPH puede conducir a cáncer de cuello uterino. 
 Sí   No  No estoy seguro 
4. VPH puede propagarse a través del contacto piel a piel. 
 Sí   No  No estoy seguro 
5. Vacuna contra el VPH previene contra todo tipo de infecciones de transmisión sexual 
(ITS). 
 Sí   No  No estoy seguro 
6. Personas que recibieron la vacuna contra el VPH no tienen que usar el condón 
durante las relaciones sexuales. 





Actitud de los padres/tutores para vacuna contra el VPH  
  
Círculo de la respuesta de su elección. 
  
1. Es importante mi niño recibir ser previa de la vacuna de VPH sexualmente activo. 
 Sí   No  No estoy seguro 
2. Será beneficioso para la salud de mi hijo si vacunados con la vacuna contra el VPH. 
 Sí   No  No estoy seguro 
3. Vacuna contra el VPH está siendo adoptada para dar dinero a las compañías 
farmacéuticas. 
 Sí   No  No estoy seguro 
4. Creo que es segura la vacuna contra el VPH. 
 Sí   No  No estoy seguro 
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5. Mi niño es demasiado joven para recibir una vacuna para ITS como VPH. 
 Sí   No  No estoy seguro 
6. La vacuna no es eficaz en la prevención del cáncer de cuello uterino o de verrugas 
genitales. 
 Sí   No  No estoy seguro 
7. Si mi niño recibe la vacuna contra el VPH, será una licencia para involucrar en la 
actividad sexual. 





Cuestionario fue desarrollado y validado por expertos en la materia (el estudiante, el 
preceptor, NPs en la oficina, incluyendo el Dr. Omar Sheriff (Gerente de la clínica). 








Appendix D: Educational Materials 
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